Status:
COMPLETED
Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome
Lead Sponsor:
Zagazig University
Conditions:
Evaluations, Diagnostic Self
Treatment Adherence
Eligibility:
FEMALE
20-33 years
Phase:
NA
Brief Summary
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of reproductive, endocrine and metabolic functions. Vitamin D has an influence on metabolic and reproductive functions. This study was desi...
Detailed Description
Background Polycystic ovarian syndrome (PCOS) is a heterogeneous disorder affecting 510% of women of reproductive age. It is a disorder that affects the reproductive, endocrine and metabolic functions...
Eligibility Criteria
Inclusion
- women with PCO. The diagnosis of PCOS was based on the 2004 revised Rotterdam criteria
- women must be able to swallow tablets
Exclusion
- a history of hyperandrogenic states (such as nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, 21-hydroxylase deficiency, or hyperprolactinemia)
- DM3-hypertension
- liver diseases
- kidney diseases
- Insulin-dependent diabetes
- thyroid diseases.
- women received non-steroidal anti-inflammatory drugs , multivitamins, and hormone replacement therapy.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT04117750
Start Date
November 1 2017
End Date
July 1 2018
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University
Zagazig, El-Shakia, Egypt, 44519